Health Catalyst(US:HCAT)2019-11-13 03:44Financial Data and Key Metrics Changes - Total revenue for Q3 2019 was $39.4 million, representing a 20% year-over-year increase [25] - Adjusted gross margin for Q3 2019 was 54%, up from 50% in Q3 2018 [7] - Adjusted EBITDA loss for Q3 2019 was $8.4 million, an improvement from a loss of $11.3 million in Q3 2018 [31] Business Line Data and Key Metrics Changes - Technology revenue was $21.2 million, a 16% increase year-over-year [25] - Professional services revenue was $18.3 million, a 25% increase year-over-year [25] - Adjusted gross margin for technology was 68%, an increase of approximately 190 basis points year-over-year [27] Market Data and Key Metrics Changes - The company reported that over 90% of its revenue is recurring, with greater than 100% dollar-based retention [44] - The healthcare analytics summit hosted over 1,600 professionals, achieving an overall satisfaction rating of greater than 99% [12] Company Strategy and Development Direction - The company is focused on enabling measurable improvements for customers while maintaining high satisfaction [8] - There is a strong emphasis on digital transformation within healthcare, with the company positioning itself as a partner to facilitate this transition [14] - The company plans to continue investing in core markets and new markets, including Life Sciences and international expansion [42] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the robustness of the sales pipeline moving into Q4 2019 and beyond [41] - The acquisition of Medicity is seen as a headwind, but management anticipates cross-sell opportunities to materialize in 2020 [43] - The company does not expect significant impacts from the political environment on its sales efforts [71] Other Important Information - The company appointed two new board members effective January 1, 2020, enhancing its leadership team [21][22] - The company ended Q3 2019 with $241.4 million in cash and short-term investments, compared to $33.2 million at the end of 2018 [34] Q&A Session Summary Question: How to think about headwinds and tailwinds looking into 2020? - Management highlighted investments in core and new markets as tailwinds, while the Medicity acquisition represents a revenue headwind [41][43] Question: How does the start of 2020 look regarding the sales pipeline? - Management feels good about the current pipeline supporting projections for Q4 and the full year 2019 [48] Question: Feedback from this year's summit compared to previous ones? - This year's summit had the highest attendance and provided significant feedback on the need for foundational analytics support [51][52] Question: Update on professional services gross margin and hiring? - Management reported progress in hiring and maintaining a sustainable pace for the professional services team [57] Question: Thoughts on the Google-related news and competition? - Management believes that cloud companies will play a significant role in the healthcare ecosystem, but the company focuses on higher-level healthcare-specific solutions [85]